Hepatic phenylalanine hydroxylase activity in hyperphenylalaninaemia

Area of Science:

• Biochemistry
• Metabolic Disorders
• Genetics

Background:

• Hyperphenylalaninaemia is a condition characterized by elevated phenylalanine levels.
• Management typically involves dietary restriction of phenylalanine.
• Accurate prediction of required dietary restriction is crucial for patient outcomes.

Purpose of the Study:

• To compare in vivo phenylalanine tolerance with ex vivo phenylalanine hydroxylase (PAH) activity in newly diagnosed hyperphenylalaninaemia cases.
• To determine if hepatic PAH activity can predict the necessary dietary phenylalanine restriction.

Main Methods:

• Analysis of 14 newly detected hyperphenylalaninaemia cases.
• Measurement of in vivo phenylalanine tolerance.
• Assay of phenylalanine hydroxylase activity in liver biopsy specimens.

Main Results:

• Hepatic phenylalanine hydroxylase activity was measured in liver biopsy samples.
• In vivo phenylalanine tolerance was assessed.
• A significant correlation between hepatic PAH activity and the degree of required dietary restriction was not found.

Conclusions:

• Liver biopsy-derived phenylalanine hydroxylase activity is not a reliable predictor of dietary phenylalanine restriction needs in hyperphenylalaninaemia.
• Clinical management may require alternative methods for determining appropriate dietary interventions.